Alexion’s $1.41 Billion Acquisiton of Portola

Cooley advised Portola on its agreement to sell to Alexion Pharmaceuticals. Skadden advised Centerview Partners, serving as exclusive financial advisor to Portola Pharmaceuticals, Inc., while Paul,…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here